Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
add, ago, baseline, Black, blocker, consecutive, constraint, cure, curve, Deposit, discovery, exacerbate, FDIC, floor, freestanding, gold, impossible, Index, inflationary, Knightbrook, Macroeconomic, military, morphogenetic, notify, novo, ODI, osteopromotive, Oswestry, path, pathway, preliminary, prepaid, progression, proportion, quotation, receivership, regain, remeasured, Russia, score, Silicon, SIPC, Ukraine, unchanged, Valley
Removed:
absence, achieving, adjustment, allocated, annum, bear, Bret, center, charge, Chester, consulted, contingently, convert, DBX, deductible, Delta, depended, depositor, discontinuance, discount, documented, enterprise, Epsilon, Etex, examination, exceeding, excellence, Exemption, feature, federally, honor, HREC, identification, influence, Injection, Japan, journal, La, lender, loan, Merck, monthly, multicenter, Neve, Omicron, page, Pathogen, Pennsylvania, Premier, premium, prime, processing, promissory, ran, Rapid, readily, returnable, Roche, RPS, scaling, secured, SkelRegen, society, taxing, threshold, Topic, uncured, utilization, West
Filing tables
Filing exhibits
BBLG similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-257484), Form S-3 (No. 333-265872) and Form S-1 (No. 333-267588) of our report dated March 30, 2023, relating to the financial statements of Bone Biologics Corporation as of and for the years ended December 31, 2022 and 2021 (which report includes an explanatory paragraph relating to substantial doubt about Bone Biologics Corporation’s ability to continue as a going concern) which appear in Bone Biologics Corporation’s Annual Report on Form 10-K for the year ended December 31, 2022.
/s/Weinberg and Company, P.A.
Los Angeles, California
March 30, 2023